Reuters Asia Business

DBS leading race to buy controlling stake in Indonesia’s Panin Bank, sources say

By Yantoultra Ngui and Kane Wu SINGAPORE/HONG KONG (Reuters) – DBS Group, Southeast Asia’s top bank by assets, is the frontrunner to buy a controlling stake in Indonesia’s Panin Bank, three people with knowledge of the matter said. The Singapore lender was competing with Malaysia’s CIMB Group in the second round of the bidding process, …

DBS leading race to buy controlling stake in Indonesia’s Panin Bank, sources say Read More »

Morgan Stanley raises Chinese stock targets again on earnings optimism

SHANGHAI (Reuters) – Wall Street firm Morgan Stanley raised on Wednesday its index targets for Chinese shares for the second time this year, citing improved earnings growth forecasts and a more optimistic outlook for the economy and currency. The bank upgraded its year-end index targets for Hong Kong’s benchmark Hang Seng Index, Hang Seng China …

Morgan Stanley raises Chinese stock targets again on earnings optimism Read More »

China’s CATL Hong Kong listing approved, sources say it could raise at least $5 billion

SYDNEY/BEIJING (Reuters) -Chinese battery giant CATL said it had received approval from China’s securities regulator for a share sale in Hong Kong that sources have said could raise at least $5 billion, the largest listing in the city for four years. The Shenzhen-listed firm plans to issue not more than around 220 million shares on …

China’s CATL Hong Kong listing approved, sources say it could raise at least $5 billion Read More »

Japan’s corporate service inflation hits 3.0%, keeps BOJ rate hike bets alive

TOKYO (Reuters) – A leading indicator of Japan’s service-sector inflation hit 3.0% in February, data showed on Wednesday, keeping alive expectations of further interest rate hikes by the central bank. Service-sector inflation is being closely watched by the Bank of Japan for clues on whether prospects of sustained wage gains will prod firms to continue …

Japan’s corporate service inflation hits 3.0%, keeps BOJ rate hike bets alive Read More »

IMF reaches staff-level deal with Pakistan to unlock $1.3 billion of new cash

By Kanishka Singh and Ariba Shahid WASHINGTON/KARACHI (Reuters) -International Monetary Fund staff reached a deal with Pakistan for a new $1.3 billion arrangement and also agreed on the first review of the ongoing 37-month bailout program, the IMF said on Tuesday. Pending board approval, Pakistan can unlock the $1.3 billion under a new climate resilience …

IMF reaches staff-level deal with Pakistan to unlock $1.3 billion of new cash Read More »

Shareholders of Thailand’s Intouch approve merger with Gulf Energy

(Reuters) – Shareholders of Thailand-based telecoms operator Intouch Holdings gave their backing on Tuesday to a planned $25 billion merger with billionaire Sarath Ratanavadi’s Gulf Energy, although the deal is still complicated by the need for affiliate companies’ approval. Gulf and Intouch announced last July that they planned to merge to combine their energy and …

Shareholders of Thailand’s Intouch approve merger with Gulf Energy Read More »

Alibaba says to restart hiring, sees signs of start of AI bubble in the US

By Kane Wu and Selena Li HONG KONG (Reuters) -Alibaba Group Chairman Joe Tsai said on Tuesday the tech giant would recommence hiring, emboldened with more confidence following President Xi Jinping’s February meeting with business entrepreneurs. He also expressed concern about some very big investment announcements in artificial intelligence in the U.S., saying it could …

Alibaba says to restart hiring, sees signs of start of AI bubble in the US Read More »

Merck buys rights to heart disease drug in latest China deal

By Sriparna Roy (Reuters) -Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, the latest in a series of deals U.S. drugmakers have recently signed with China-based firms. Large drugmakers including Merck and Eli Lilly have turned to Chinese biotechs for deals that give …

Merck buys rights to heart disease drug in latest China deal Read More »

Trump’s port fees on Chinese ships threaten US maritime industry, say executives

By Lisa Baertlein and David Lawder LOS ANGELES/WASHINGTON (Reuters) – President Donald Trump’s plan to revitalize the U.S. shipbuilding industry is likely to backfire because it relies on proposed fees on China-linked vessels that will hurt domestic ship operators, seaports, exporters and jobs, industry executives said at U.S. Trade Representative hearings on Monday. At issue …

Trump’s port fees on Chinese ships threaten US maritime industry, say executives Read More »

Close Bitnami banner
Bitnami